[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

EIS Eczacibasi Ilaç Sanayi ve Ticaret A.S. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

EIS Eczacibasi Ilaç Sanayi ve Ticaret A.S. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

ALK-Abelló A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ALK-Abelló A/S Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Advanced Viral Research Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advanced Viral Research Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Advanced Proteome Therapeutics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advanced Proteome Therapeutics Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Advanced Life Sciences Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advanced Life Sciences Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Advanced Cell Technology Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advanced Cell Technology Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Adolor Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adolor Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Adimmune Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adimmune Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Adherex Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adherex Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Adeona Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adeona Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Addex Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Addex Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Adcock Ingram Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adcock Ingram Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Adamis Pharmaceuticals Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adamis Pharmaceuticals Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Acuvax Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acuvax Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Acusphere Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acusphere Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Acura Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acura Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

ActiveCare, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ActiveCare, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Active Biotech AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Active Biotech AB Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Actinogen Limited. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Actinogen Limited. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Actelion Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Actelion Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Acrux Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acrux Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Acron Genomics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acron Genomics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Acorda Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acorda Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Acino Holding AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acino Holding AG Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Achillion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Achillion Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Access Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Access Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Accentia Biopharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Accentia Biopharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Accelrys Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Accelrys Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Accelr8 Technology Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Accelr8 Technology Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Accelerator Nordic AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Accelerator Nordic AB Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Accel Transmatic Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Accel Transmatic Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

ACADIA Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ACADIA Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Abviva, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abviva, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Abnova (Taiwan) Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abnova (Taiwan) Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Ablynx NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ablynx NV Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

ABL Bio-Technologies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ABL Bio-Technologies Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Abcam Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abcam Plc Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Abbott Laboratories (Pakistan) Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abbott Laboratories (Pakistan) Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Abbott Laboratories Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company’s segments include Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products...

March 2024 72 pages

Abbott India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abbott India Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

AB-Biotics SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AB-Biotics SA Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

AB Science S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AB Science S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Vericel Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vericel Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Aarti Drugs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aarti Drugs Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Aarey Drugs & Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aarey Drugs & Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

A.L. Industrier ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

A.L. Industrier ASA Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

A-Viral AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

A-Viral AS Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Advaxis Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advaxis Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Adventrx Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adventrx Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Advik Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advik Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers